BPA Call 75H71224A00011-75H71225F28002

Award Date 6/11/25
Potential Completion Date 6/16/26
Potential Value $181K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Phoenix, AZ 85016, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The $154,150.00 contract is for the delivery of in vitro diagnostic substances, reagents, test kits, and sets, with a period of performance ending on September 30, 2018. There was no set-aside designation used for this award. Meridian Bioscience...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic substances, reagents, test kits, and sets. The $167,063 contract provides clinical diagnostic products and supplies to support federal health and screening programs. Meridian Bioscience has previously delivered COVID-19 tests, lead testing systems, hepatitis assays,...
This is a BPA Call contract awarded by the Indian Health Service, a civilian agency, to Biomerieux Inc. for $172,680.00. The contract is for the provision of test kits and quality control products, with a period of performance running until March 26, 2026. The contract does not have a set-aside designation. Biomerieux Inc., a global leader in in vitro diagnostics, will be the prime contractor providing its specialized diagnostic platforms, reagents, and test kits to support infectious disease...
This contract award is for a Blanket Purchase Agreement (BPA) call slip from the Indian Health Service (IHS) to Biomerieux Inc., a global leader in in vitro diagnostics. The $236,953.95 firm-fixed-price contract covers the procurement of Biomerieux diagnostic supplies, including reagents and test kits, to support the IHS's clinical laboratory operations. Biomerieux Inc. is the prime contractor and holds several Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $194 million...
The U.S. Department of Health and Human Services, Indian Health Service awarded a Blanket Purchase Agreement (BPA) call order to Biomerieux Inc. for BioFire panel reagents. The contract has a ceiling value of $1,216,476.00 and a period of performance through May 5, 2026. This BPA call order is under the larger Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits, which allows various federal agencies to procure Biomerieux's proprietary diagnostic products and...
This federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, involves the supply of BIOMERIEUX PREVICOLOR SUPPLIES against a Blanket Purchase Agreement (BPA) with the Indian Health Service, a civilian agency within the Department of Health and Human Services. The award, valued at $13,419.95, is a firm-fixed-price contract call under a Multiple Award Schedule (MAS) contract. The contract has no set-aside designation and provides for the delivery of specialized...
The federal contract award is for a Blanket Purchase Agreement (BPA) Call from the Indian Health Service, a civilian agency, to Biomerieux Inc. for the VIDAS 3 BPA. The contract has a ceiling value of $162,000.00 and a completion date of August 19, 2029. Biomerieux Inc., a for-profit organization and manufacturer of goods, is the prime contractor. The contract does not have a set-aside designation. This award is part of a larger Indefinite Delivery Vehicle (IDV) and Federal Supply Schedule...
This federal contract award to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments, is for the provision of laboratory reagents for the Centers for Disease Control and Prevention (CDC) Pittsburgh facility. The contract, valued at $49,466.00, is a firm fixed-price purchase order with an ultimate completion date of November 1, 2024. The contract does not have a set-aside designation. Meridian Bioscience is a key supplier of...
This federal contract award is a Blanket Purchase Agreement (BPA) Call valued at $69,870.49 to Biomerieux Inc., a global leader in in vitro diagnostics. The contract was awarded by the Indian Health Service, a civilian agency, for the provision of BioFire panel reagents. The contract has no set-aside designation and is being fulfilled under the In Vitro Diagnostics, Reagents, Test (FSS-65-VII) Federal Supply Schedule contract. Biomerieux Inc., through its Vitek Systems, Inc. division, has been...
This firm-fixed-price blanket purchase agreement (BPA) call was awarded by the Department of Health and Human Services' Indian Health Service to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $13,419.85, covers the supply of Biomerieux's proprietary microbiology testing equipment, reagents, and consumables for the period of July 1, 2024 to June 30, 2025. The award is placed under Biomerieux's existing Multiple Award Schedule (MAS) contract, which allows federal...
  • 75H71224A00011
    Blanket Purchase Agreement
  • 75H71224A00011-75H71225F28002
    BPA Call

This is a Blanket Purchase Agreement (BPA) call awarded by the Indian Health Service (IHS), a civilian agency, to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits and medical equipment. The BPA call, valued at $181,425.00, is for the procurement of laboratory supplies and an extended warranty for the Meridian Bioscience BREATH ID Smart System. The contract does not have a set-aside designation and has a period of performance through June 16, 2026. Meridian Bioscience is the prime contractor and has previously secured several federal contracts and grants, including a $931,985.00 BPA with IHS for the BREATH ID Smart System and related services. This contract supports the IHS's mission of providing comprehensive healthcare services to American Indian and Alaska Native populations.

Generated 6/13/25, 9:55 AM